Chromocenter logo — Pioneering a new age in biopharmaceuticals with advanced art...

Chromocenter

Pioneering a new age in biopharmaceuticals with advanced artificial chromosome vector technology for groundbreaking drug discovery.

Founded 2005 Venture round Total: $558.00M Biopharma, Biotechnology +2

General Information

Company Name Chromocenter
Founded Year 2005
Industries Biopharma, Biotechnology, Manufacturing +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Chromocenter. To contact Chromocenter, visit chromocenter.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Chromocenter

Chromocenter is a pioneering biopharmaceuticals company that leverages advanced artificial chromosome vector technology for groundbreaking drug discovery. Founded in 2005, the company operates within the Biopharma, Biotechnology, Manufacturing, and Pharmaceutical industries, specializing in the development of innovative medical pharmaceuticals. Chromocenter's most recent milestone is securing a Venture Round investment on 24 March 2021, with the investment coming from Shinkin Capital. With a focus on cutting-edge technology and drug discovery, Chromocenter is at the forefront of revolutionizing the biopharmaceuticals industry.

Taxonomy: Biopharmaceuticals, Drug discovery, Artificial chromosome vectors, Medical pharmaceuticals, Advanced technology, Biopharmaceutical manufacturing, Innovative drug development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Shinkin Capital
24 Mar 2021
Corporate Round Undisclosed 1
Itochu
13 Jul 2020
Venture Round ¥217.00M 4
Mitsubishi UFJ Capital, Shinkin Capital +2
20 Jul 2018
Venture Round ¥150.00M 2
Minato Capital, Osaka University Venture Capital
08 Jun 2018
Venture Round ¥191.00M 2
SMBC Venture Capital, Osaka University Venture Capital
18 Aug 2016

Chromocenter Alternatives & Competitors

View All Alternatives
Chromocenter vs

A pioneering chemoproteiomics-based drug discovery and development firm with bases in Seoul, Korea,...

Series B
2-10 employees
Biotechnology, Health Care
Chromocenter vs

Innovating to meet critical health challenges with advanced therapeutic discoveries and developments...

Venture round
Biopharma, Biotechnology
Chromocenter vs

Empowering healthcare with advanced graphene biosensors for accelerated life science and drug discov...

Series A
Biotechnology, Health Care

FAQ About Chromocenter

Pioneering a new age in biopharmaceuticals with advanced artificial chromosome vector technology for groundbreaking drug discovery.
Chromocenter was founded in 2005.
Chromocenter operates in Biopharma, Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Biopharmaceuticals, Drug discovery, Artificial chromosome vectors and Medical pharmaceuticals.
Chromocenter has completed 5 funding rounds, raising a total of $558.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Chromocenter include CG Pharmaceuticals, Pharmacopeia, Nanomed, Santaris Pharma, NTpharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Chromocenter and CG Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Chromocenter, https://bouncewatch.com/company/chromocenter, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes